Transaction Details

Footnotes

Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022. | This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026. | Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. | On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. The Class a common stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.